•
Mar 31, 2024

Allovir Q1 2024 Earnings Report

Total Revenue
$0
EPS
-$0.26
Previous year: -$0.44
-40.9%
Gross Profit
$0
Cash and Equivalents
$141M
Previous year: $203M
-30.6%
Free Cash Flow
-$44.4M
Total Assets
$144M
Previous year: $244M
-40.9%

Allovir

Allovir